PABPN1 prevents the nuclear export of an unspliced RNA with a constitutive transport element and controls human gene expression via intron retention
RNA · 2023
DOI: 10.1261/rna.079294.122 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, 2023. Verfasst von Lauren Kwiatek und 4 weiteren Autor:innen. Beteiligte Einrichtung: RNA Group, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, Canada J1E 4K8. Hauptthemen laut MEDLINE: RNA Splicing, Cell Nucleus. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR, Fonds de recherche du Québec—Santé, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Intron retention is a type of alternative splicing where one or more introns remain unspliced in a polyadenylated transcript. Although many viral systems are known to translate proteins from mRNAs with retained introns, restriction mechanisms generally prevent export and translation of incompletely spliced mRNAs. Here, we provide evidence that the human nuclear poly(A)-binding protein, PABPN1, functions in such restrictions. Using a reporter construct in which nuclear export of an incompletely spliced mRNA is enhanced by a viral constitutive transport element (CTE), we show that PABPN1 depletion results in a significant increase in export and translation from the unspliced CTE-containing transcript. Unexpectedly, we find that inactivation of poly(A)-tail exosome targeting by depletion of PAXT components had no effect on export and translation of the unspliced reporter mRNA, suggesting a mechanism largely independent of nuclear RNA decay. Interestingly, a PABPN1 mutant selectively defective in stimulating poly(A) polymerase elongation strongly enhanced the expression of the unspliced, but not of intronless, reporter transcripts. Analysis of RNA-seq data also revealed that PABPN1 controls the expression of many human genes via intron retention. Notably, PABPN1-dependent intron retention events mostly affected 3′-terminal introns and were insensitive to PAXT and NEXT deficiencies. Our findings thus disclose a role for PABPN1 in restricting nuclear export of intron-retained transcripts and reinforce the interdependence between terminal intron splicing, 3′ end processing, and polyadenylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RNA Group, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, Canada J1E 4K8.
- RNA Group, Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, Québec, Canada J1E 4K8 f.bachand@usherbrooke.ca.
ORCID-Profile: Francois Bachand
Förderung
- CIHR
- Fonds de recherche du Québec—Santé
- Canadian Institutes of Health Research
Zitieren
APA
Kwiatek, L., Landry-Voyer, A. M., Latour, M., Yague-Sanz, C., & Bachand, F. (2023). PABPN1 prevents the nuclear export of an unspliced RNA with a constitutive transport element and controls human gene expression via intron retention. RNA. https://doi.org/10.1261/rna.079294.122
Vancouver
Kwiatek L, Landry-Voyer AM, Latour M, Yague-Sanz C, Bachand F. PABPN1 prevents the nuclear export of an unspliced RNA with a constitutive transport element and controls human gene expression via intron retention. RNA. 2023. doi:10.1261/rna.079294.122
BibTeX
@article{Kwiatek2023,
author = {Kwiatek, Lauren and Landry-Voyer, Anne-Marie and Latour, Mélodie and Yague-Sanz, Carlo and Bachand, Francois},
title = {PABPN1 prevents the nuclear export of an unspliced RNA with a constitutive transport element and controls human gene expression via intron retention},
journal = {RNA},
year = {2023},
doi = {10.1261/rna.079294.122}
}
EUVIMED